InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.01%
)
US TECH 100
19,324.00
(
0.38%
)
Dow Jones
42,196.52
(
0.09%
)
Brent Oil
74.89
(
0.36%
)
Bitcoin
61,117.85
(
0.81%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

glass_half_full

Send PM Follow Ignore
Followers 6
Posts 1203
Boards Moderated 0
Alias Born 12/09/2006

glass_half_full

Re: biotech_researcher post# 72597

Tuesday, 04/26/2016 2:15:27 PM

Tuesday, April 26, 2016 2:15:27 PM

Post# of 80490
Both seem to be true -- Ariad people said not to think that they have other drugs, and they did publish about this choline kinase alpha molecule.

I agree it's not really congruent.

Bull case is that CHKA is a study compound that can be part of the pipeline.

Base (and also bear) case is that CHKA has hurdles that are too high so they published the paper because that's all the payoff CHKA can give.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up